FDA Wants All Zantac Heartburn Medication Including Generics Removed From Shelves
The FDA asked companies on April 1, 2020 to stop selling all forms of the heartburn drug Zantac after they concluded a potential cancer causing contaminant can build up in the drug when stored for a long period of time. The agency also recommended consumers who use the over-the-counter forms